Investigational Small-Molecule Drug Selectively Suppresses Constitutive CYP2B6 Activity at the Gene Transcription Level: Physiologically Based Pharmacokinetic Model Assessment of Clinical Drug Interaction Risk
2014 ◽
Vol 42
(6)
◽
pp. 1008-1015
◽
2019 ◽
Vol 8
(9)
◽
pp. 685-695
◽
2017 ◽
Vol 106
(5)
◽
pp. 1439-1451
◽
1997 ◽
Vol 17
(5)
◽
pp. 583-598
◽
2012 ◽
Vol 91
(4)
◽
pp. 700-708
◽
2018 ◽
Vol 39
(3)
◽
pp. 152-163
◽
2020 ◽
Vol 59
(9)
◽
pp. 1149-1160
◽
2015 ◽
Vol 55
(6)
◽
pp. 735-749
◽